KITLG and neoplasm: We speculated that since SCF and PDGF-beta seem to encourage the growth of this tumor through interactions with receptors on tumor cells and/or bystander cells; the thought of blocking of these receptors with multiselective kinase inhibitors such as imatinib or sunitinib could be entertained.